PubMed Health⌕ Search

Biomedical subjects

B J Classon

Publications and source records attributed to B J Classon.

22 records · Page 2Linked to original sources

Partial primary structure of the T4 antigens of mouse and sheep: assignment of intrachain disulfide bonds.

The T4 antigens of mouse and sheep have been purified to homogeneity and partially sequenced using protein and peptide microsequencing techniques. Both mouse and sheep antigens bear distinct homology to human T4, having an amino-terminal segment that is homologous to the K-chain variable region (VK). A surprisingly high degree of sequence divergence was nevertheless evident between the T4 antigens of the three mammalian species, suggesting an unusually rapid rate of evolution that is possibly related to the functional role of T4 in class II major histocompatibility complex antigen recognition. The mouse and sheep T4 antigens contain at least three intrachain disulfide bonds which in all cases connect adjacent cysteine residues. All three intrachain disulfide linkages are situated within the putative extracellular domain, and the amino-terminal disulfide bond probably involves the two cysteine residues homologous to those which form the intrachain bridge within the VK domain of immunoglobulin molecules. The structural relationship of the T4 antigen to other members of the immunoglobulin supergene family is discussed.

Amino Acid Sequence↗

Specific targeting of chlorambucil to tumors with the use of monoclonal antibodies.

The concept of attaching cytotoxic drugs, such as the alkylating agent chlorambucil (CBL), to "tumor-specific" antibodies for the treatment of cancer is attractive, inasmuch as the specificity of CBL could be increased and its systemic toxicity reduced. To this end, CBL was activated by N-hydroxysuccinimide to produce an active ester derivative that was covalently coupled to monoclonal antibodies reactive with murine cell surface antigens. Up to 30 molecules of CBL were specifically bound per molecule of antibody, without impairing the alkylating activity of CBL and with minimal loss of antibody activity. The in vitro cytotoxicity of the conjugate was tested by the inhibition in [3H]thymidine incorporation into tumor cells, which demonstrated the conjugate to be specifically cytotoxic toward antibody-reactive cell lines, having more activity than the free drug. In vivo treatment of (C57BL/6 X BALB/c)F1 mice bearing a murine thymoma with CBL-antibody conjugates gave prolonged survival times and greater inhibition of growth of established tumors than was obtained with free antibody or CBL alone. The study is one of the first examples of the greater toxicity of a drug coupled to antibody, inasmuch as most drugs when coupled to antibody lose activity. CBL-monoclonal antibody conjugates may, therefore, provide a means of specifically attacking tumors, which could be therapeutically useful.

Animals↗